Literature DB >> 8216759

Disturbance of colour perception in Parkinson's disease.

T Büttner1, W Kuhn, P Klotz, R Steinberg, L Voss, D Bulgaru, H Przuntek.   

Abstract

A computer-aided method for the determination of colour fusion time (CFT) was developed. CFT indicates the acuity of the perception of monochromatic contours. CFT was determined in 36 patients with Parkinson's disease (PD) and compared with a group of 36 age- and sex-matched controls. Patients with PD generally had a shortened fusion time, especially for dark-green, light-blue and dark-red stimuli. The results give evidence to the hypothesis of a colour perception disorder in PD. The physiological and pathoanatomical basis of this phenomenon is unknown, but a functional deficit of cortical neurons may be a probable cause.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8216759     DOI: 10.1007/bf02252618

Source DB:  PubMed          Journal:  J Neural Transm Park Dis Dement Sect        ISSN: 0936-3076


  7 in total

1.  Phosphorylated α-synuclein in the retina is a biomarker of Parkinson's disease pathology severity.

Authors:  Isabel Ortuño-Lizarán; Thomas G Beach; Geidy E Serrano; Douglas G Walker; Charles H Adler; Nicolás Cuenca
Journal:  Mov Disord       Date:  2018-05-08       Impact factor: 10.338

2.  Relation of Parkinson's disease subtypes to visual activities of daily living.

Authors:  Daniel R Seichepine; Sandy Neargarder; Ivy N Miller; Tatiana M Riedel; Grover C Gilmore; Alice Cronin-Golomb
Journal:  J Int Neuropsychol Soc       Date:  2011-08-04       Impact factor: 2.892

3.  Visual hallucinosis: the major clinical determinant of distorted chromatic contour perception in Parkinson's disease.

Authors:  T Büttner; W Kuhn; T Müller; F L Welter; J Federlein; K Heidbrink; H Przuntek
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

4.  Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects.

Authors:  Thomas G Beach; Jeremiah Carew; Geidy Serrano; Charles H Adler; Holly A Shill; Lucia I Sue; Marwan N Sabbagh; Haruhiko Akiyama; Nicolás Cuenca
Journal:  Neurosci Lett       Date:  2014-04-28       Impact factor: 3.046

5.  Visual symptoms in Parkinson's disease.

Authors:  R A Armstrong
Journal:  Parkinsons Dis       Date:  2011-05-25

6.  How I do it: The Neuro-Ophthalmological Assessment in Parkinson's Disease.

Authors:  Carlijn D J M Borm; Katarzyna Smilowska; Nienke M de Vries; Bastiaan R Bloem; Thomas Theelen
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

Review 7.  Oculo-Visual Dysfunction in Parkinson's Disease.

Authors:  R A Armstrong
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.